We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Software Measures Platelet Fraction

By HospiMedica staff writers
Posted on 09 Nov 2005
Specialized master software programs are designed to assist with the diagnosis and treatment of altered platelet and red-cell production.

More specifically, the software is designed to measure immature platelet fraction (IPF) and reticulocyte hemoglobin equivalent (RET-He) on the XE-2100 hematology analyzers of Sysmex Corp. More...
(Kobe, Japan; www.sysmex.co.jp). All of the cells sampled on the X-series of instruments are exposed to fluorescent dyes with affinity for nucleic acids.

"The Immature Platelet Fraction is an index of thrombopoiesis,” said Ian Giles, M.D., medical director, Sysmex America. "It can determine the origin of thrombocytopenia by helping to distinguish between bone marrow failure and peripheral platelet consumption or destruction.”

The RET-He parameter provides a direct measurement for the mean reticulocyte hemoglobin content in picograms. It is therefore a useful parameter for the early diagnosis of iron deficiency (iron restricted erthropoiesis) and for optimizing iron therapy.

"Release of the new master software programs for the XE-2100 indicates Sysmex's commitment to our ongoing improvement of XE-2100 fluorescent flow cytometry technology,” said Peggy Barranco, product manager, Sysmex America. The Sysmex XE-2100 is now in more than 6,000 laboratories worldwide.




Related Links:
Sysmex Corp.

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.